nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—TEK—coronary artery disease	0.167	0.465	CbGaD
Regorafenib—KDR—coronary artery disease	0.0816	0.227	CbGaD
Regorafenib—KIT—coronary artery disease	0.077	0.214	CbGaD
Regorafenib—CYP2C19—coronary artery disease	0.0335	0.0933	CbGaD
Regorafenib—UGT1A1—Ezetimibe—coronary artery disease	0.0153	0.0417	CbGbCtD
Regorafenib—UGT1A1—Simvastatin—coronary artery disease	0.0143	0.0388	CbGbCtD
Regorafenib—UGT1A1—Lovastatin—coronary artery disease	0.014	0.0379	CbGbCtD
Regorafenib—UGT1A1—Atorvastatin—coronary artery disease	0.0127	0.0346	CbGbCtD
Regorafenib—UGT1A1—Losartan—coronary artery disease	0.0116	0.0316	CbGbCtD
Regorafenib—ABCG2—Telmisartan—coronary artery disease	0.0114	0.0311	CbGbCtD
Regorafenib—ABCG2—Pitavastatin—coronary artery disease	0.0114	0.0311	CbGbCtD
Regorafenib—CYP2C8—Fenofibrate—coronary artery disease	0.0101	0.0274	CbGbCtD
Regorafenib—CYP2B6—Clopidogrel—coronary artery disease	0.00921	0.025	CbGbCtD
Regorafenib—ABCG2—Rosuvastatin—coronary artery disease	0.00844	0.0229	CbGbCtD
Regorafenib—ABCG2—Ezetimibe—coronary artery disease	0.00844	0.0229	CbGbCtD
Regorafenib—CYP2C8—Gemfibrozil—coronary artery disease	0.00805	0.0219	CbGbCtD
Regorafenib—ABCG2—Pravastatin—coronary artery disease	0.00768	0.0209	CbGbCtD
Regorafenib—ABCB1—Ticagrelor—coronary artery disease	0.00764	0.0208	CbGbCtD
Regorafenib—CYP2C9—Fenofibrate—coronary artery disease	0.00702	0.0191	CbGbCtD
Regorafenib—CYP2C8—Clopidogrel—coronary artery disease	0.00698	0.019	CbGbCtD
Regorafenib—CYP2C19—Gemfibrozil—coronary artery disease	0.00675	0.0184	CbGbCtD
Regorafenib—CYP2C8—Pitavastatin—coronary artery disease	0.0061	0.0166	CbGbCtD
Regorafenib—CYP2C19—Clopidogrel—coronary artery disease	0.00585	0.0159	CbGbCtD
Regorafenib—CYP2C9—Gemfibrozil—coronary artery disease	0.00561	0.0153	CbGbCtD
Regorafenib—CYP2B6—Simvastatin—coronary artery disease	0.00552	0.015	CbGbCtD
Regorafenib—CYP2C19—Telmisartan—coronary artery disease	0.00512	0.0139	CbGbCtD
Regorafenib—CYP2B6—Atorvastatin—coronary artery disease	0.00492	0.0134	CbGbCtD
Regorafenib—CYP2C9—Clopidogrel—coronary artery disease	0.00487	0.0132	CbGbCtD
Regorafenib—ABCB1—Perindopril—coronary artery disease	0.00472	0.0128	CbGbCtD
Regorafenib—ABCB1—Clopidogrel—coronary artery disease	0.00472	0.0128	CbGbCtD
Regorafenib—CYP3A4—Ticagrelor—coronary artery disease	0.00458	0.0124	CbGbCtD
Regorafenib—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00438	0.0119	CbGbCtD
Regorafenib—CYP2C9—Pitavastatin—coronary artery disease	0.00425	0.0116	CbGbCtD
Regorafenib—CYP2C8—Simvastatin—coronary artery disease	0.00418	0.0114	CbGbCtD
Regorafenib—CYP2C9—Valsartan—coronary artery disease	0.00414	0.0112	CbGbCtD
Regorafenib—ABCB1—Pitavastatin—coronary artery disease	0.00413	0.0112	CbGbCtD
Regorafenib—ABCB1—Telmisartan—coronary artery disease	0.00413	0.0112	CbGbCtD
Regorafenib—CYP2C19—Timolol—coronary artery disease	0.00412	0.0112	CbGbCtD
Regorafenib—CYP2C8—Pravastatin—coronary artery disease	0.00409	0.0111	CbGbCtD
Regorafenib—CYP2C8—Lovastatin—coronary artery disease	0.00409	0.0111	CbGbCtD
Regorafenib—CYP3A4—Fenofibrate—coronary artery disease	0.00408	0.0111	CbGbCtD
Regorafenib—ABCB1—Enalapril—coronary artery disease	0.00391	0.0106	CbGbCtD
Regorafenib—ABCB1—Lisinopril—coronary artery disease	0.00391	0.0106	CbGbCtD
Regorafenib—CYP2C19—Rosuvastatin—coronary artery disease	0.00377	0.0103	CbGbCtD
Regorafenib—CYP2C8—Atorvastatin—coronary artery disease	0.00372	0.0101	CbGbCtD
Regorafenib—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00367	0.00999	CbGbCtD
Regorafenib—CYP2C19—Simvastatin—coronary artery disease	0.00351	0.00953	CbGbCtD
Regorafenib—CYP2C19—Lovastatin—coronary artery disease	0.00343	0.00933	CbGbCtD
Regorafenib—CYP2C8—Losartan—coronary artery disease	0.00341	0.00926	CbGbCtD
Regorafenib—ABCB1—Timolol—coronary artery disease	0.00333	0.00904	CbGbCtD
Regorafenib—CYP3A4—Gemfibrozil—coronary artery disease	0.00326	0.00887	CbGbCtD
Regorafenib—CYP2C9—Rosuvastatin—coronary artery disease	0.00314	0.00852	CbGbCtD
Regorafenib—CYP2C19—Atorvastatin—coronary artery disease	0.00312	0.0085	CbGbCtD
Regorafenib—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00306	0.00831	CbGbCtD
Regorafenib—ABCB1—Ezetimibe—coronary artery disease	0.00304	0.00827	CbGbCtD
Regorafenib—EPHA2—pulmonary artery—coronary artery disease	0.00301	0.0686	CbGeAlD
Regorafenib—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00297	0.00806	CbGbCtD
Regorafenib—ABCB1—Captopril—coronary artery disease	0.00293	0.00796	CbGbCtD
Regorafenib—CYP2C9—Simvastatin—coronary artery disease	0.00291	0.00792	CbGbCtD
Regorafenib—CYP2C19—Losartan—coronary artery disease	0.00286	0.00777	CbGbCtD
Regorafenib—CYP2C9—Pravastatin—coronary artery disease	0.00285	0.00775	CbGbCtD
Regorafenib—CYP2C9—Lovastatin—coronary artery disease	0.00285	0.00775	CbGbCtD
Regorafenib—CYP3A4—Clopidogrel—coronary artery disease	0.00283	0.00769	CbGbCtD
Regorafenib—ABCB1—Simvastatin—coronary artery disease	0.00283	0.00769	CbGbCtD
Regorafenib—ABCB1—Lovastatin—coronary artery disease	0.00277	0.00753	CbGbCtD
Regorafenib—ABCB1—Pravastatin—coronary artery disease	0.00277	0.00753	CbGbCtD
Regorafenib—CYP2C9—cardial valve—coronary artery disease	0.00264	0.0601	CbGeAlD
Regorafenib—CYP3A4—Eplerenone—coronary artery disease	0.00263	0.00715	CbGbCtD
Regorafenib—CYP2C9—Atorvastatin—coronary artery disease	0.0026	0.00706	CbGbCtD
Regorafenib—ABCB1—Atorvastatin—coronary artery disease	0.00252	0.00685	CbGbCtD
Regorafenib—CYP2C9—Losartan—coronary artery disease	0.00238	0.00646	CbGbCtD
Regorafenib—CYP3A4—Enalapril—coronary artery disease	0.00234	0.00637	CbGbCtD
Regorafenib—ABCB1—Losartan—coronary artery disease	0.00231	0.00627	CbGbCtD
Regorafenib—RET—autonomic nervous system—coronary artery disease	0.00211	0.0481	CbGeAlD
Regorafenib—CYP3A4—Ezetimibe—coronary artery disease	0.00182	0.00496	CbGbCtD
Regorafenib—CYP3A4—Rosuvastatin—coronary artery disease	0.00182	0.00496	CbGbCtD
Regorafenib—CYP3A4—Simvastatin—coronary artery disease	0.00169	0.00461	CbGbCtD
Regorafenib—CYP3A4—Pravastatin—coronary artery disease	0.00166	0.00451	CbGbCtD
Regorafenib—CYP3A4—Lovastatin—coronary artery disease	0.00166	0.00451	CbGbCtD
Regorafenib—CYP3A4—Atorvastatin—coronary artery disease	0.00151	0.00411	CbGbCtD
Regorafenib—CYP3A4—Losartan—coronary artery disease	0.00138	0.00376	CbGbCtD
Regorafenib—Sorafenib—RALBP1—coronary artery disease	0.00129	0.488	CrCbGaD
Regorafenib—DDR2—myocardium—coronary artery disease	0.00117	0.0267	CbGeAlD
Regorafenib—FLT4—endothelium—coronary artery disease	0.00114	0.0261	CbGeAlD
Regorafenib—TEK—artery—coronary artery disease	0.00109	0.0248	CbGeAlD
Regorafenib—FLT1—artery—coronary artery disease	0.00105	0.024	CbGeAlD
Regorafenib—TEK—endothelium—coronary artery disease	0.00092	0.021	CbGeAlD
Regorafenib—KDR—artery—coronary artery disease	0.00089	0.0203	CbGeAlD
Regorafenib—FLT1—endothelium—coronary artery disease	0.00089	0.0203	CbGeAlD
Regorafenib—DDR2—heart—coronary artery disease	0.000819	0.0187	CbGeAlD
Regorafenib—MAPK11—heart—coronary artery disease	0.000776	0.0177	CbGeAlD
Regorafenib—DDR2—cardiovascular system—coronary artery disease	0.000773	0.0176	CbGeAlD
Regorafenib—KDR—endothelium—coronary artery disease	0.000752	0.0171	CbGeAlD
Regorafenib—FGFR1—myocardium—coronary artery disease	0.000705	0.0161	CbGeAlD
Regorafenib—KIT—endothelium—coronary artery disease	0.000666	0.0152	CbGeAlD
Regorafenib—TEK—cardiac ventricle—coronary artery disease	0.000611	0.0139	CbGeAlD
Regorafenib—FLT1—cardiac ventricle—coronary artery disease	0.000591	0.0135	CbGeAlD
Regorafenib—RAF1—cardiac ventricle—coronary artery disease	0.000587	0.0134	CbGeAlD
Regorafenib—BRAF—heart—coronary artery disease	0.000579	0.0132	CbGeAlD
Regorafenib—Sorafenib—KDR—coronary artery disease	0.000578	0.218	CrCbGaD
Regorafenib—TEK—myocardium—coronary artery disease	0.000575	0.0131	CbGeAlD
Regorafenib—FLT1—myocardium—coronary artery disease	0.000556	0.0127	CbGeAlD
Regorafenib—EPHX2—heart—coronary artery disease	0.000553	0.0126	CbGeAlD
Regorafenib—RAF1—myocardium—coronary artery disease	0.000552	0.0126	CbGeAlD
Regorafenib—Sorafenib—KIT—coronary artery disease	0.000545	0.206	CrCbGaD
Regorafenib—KDR—cardiac ventricle—coronary artery disease	0.000499	0.0114	CbGeAlD
Regorafenib—FLT4—heart—coronary artery disease	0.000499	0.0114	CbGeAlD
Regorafenib—FGFR1—heart—coronary artery disease	0.000492	0.0112	CbGeAlD
Regorafenib—FLT4—cardiovascular system—coronary artery disease	0.000471	0.0107	CbGeAlD
Regorafenib—KDR—myocardium—coronary artery disease	0.00047	0.0107	CbGeAlD
Regorafenib—RET—heart—coronary artery disease	0.00044	0.01	CbGeAlD
Regorafenib—PDGFRB—cardiac ventricle—coronary artery disease	0.000432	0.00985	CbGeAlD
Regorafenib—BRAF—blood—coronary artery disease	0.000432	0.00984	CbGeAlD
Regorafenib—FGFR1—cardiac atrium—coronary artery disease	0.000421	0.00959	CbGeAlD
Regorafenib—KIT—myocardium—coronary artery disease	0.000416	0.00948	CbGeAlD
Regorafenib—EPHX2—blood—coronary artery disease	0.000413	0.0094	CbGeAlD
Regorafenib—EPHA2—heart—coronary artery disease	0.000411	0.00937	CbGeAlD
Regorafenib—PDGFRB—myocardium—coronary artery disease	0.000407	0.00926	CbGeAlD
Regorafenib—TEK—heart—coronary artery disease	0.000401	0.00914	CbGeAlD
Regorafenib—FGFR2—cardiovascular system—coronary artery disease	0.000395	0.009	CbGeAlD
Regorafenib—EPHA2—cardiovascular system—coronary artery disease	0.000388	0.00884	CbGeAlD
Regorafenib—FLT1—heart—coronary artery disease	0.000388	0.00884	CbGeAlD
Regorafenib—RAF1—heart—coronary artery disease	0.000386	0.00879	CbGeAlD
Regorafenib—ABL1—cardiac ventricle—coronary artery disease	0.000385	0.00878	CbGeAlD
Regorafenib—TEK—cardiovascular system—coronary artery disease	0.000379	0.00863	CbGeAlD
Regorafenib—FLT4—blood—coronary artery disease	0.000372	0.00848	CbGeAlD
Regorafenib—FLT1—cardiovascular system—coronary artery disease	0.000366	0.00834	CbGeAlD
Regorafenib—RAF1—cardiovascular system—coronary artery disease	0.000364	0.00829	CbGeAlD
Regorafenib—PDGFRA—heart—coronary artery disease	0.000363	0.00828	CbGeAlD
Regorafenib—ABL1—myocardium—coronary artery disease	0.000362	0.00826	CbGeAlD
Regorafenib—EPHA2—cardiac atrium—coronary artery disease	0.000352	0.00801	CbGeAlD
Regorafenib—TEK—cardiac atrium—coronary artery disease	0.000343	0.00782	CbGeAlD
Regorafenib—PDGFRA—cardiovascular system—coronary artery disease	0.000343	0.00781	CbGeAlD
Regorafenib—FLT1—cardiac atrium—coronary artery disease	0.000332	0.00756	CbGeAlD
Regorafenib—RAF1—cardiac atrium—coronary artery disease	0.00033	0.00751	CbGeAlD
Regorafenib—RET—blood—coronary artery disease	0.000329	0.00749	CbGeAlD
Regorafenib—KDR—heart—coronary artery disease	0.000328	0.00747	CbGeAlD
Regorafenib—FGFR2—blood—coronary artery disease	0.000312	0.00711	CbGeAlD
Regorafenib—KDR—cardiovascular system—coronary artery disease	0.000309	0.00705	CbGeAlD
Regorafenib—EPHA2—blood—coronary artery disease	0.000307	0.00699	CbGeAlD
Regorafenib—TEK—blood—coronary artery disease	0.000299	0.00682	CbGeAlD
Regorafenib—KIT—heart—coronary artery disease	0.000291	0.00662	CbGeAlD
Regorafenib—FLT1—blood—coronary artery disease	0.000289	0.00659	CbGeAlD
Regorafenib—RAF1—blood—coronary artery disease	0.000288	0.00656	CbGeAlD
Regorafenib—PDGFRB—heart—coronary artery disease	0.000284	0.00647	CbGeAlD
Regorafenib—KDR—cardiac atrium—coronary artery disease	0.00028	0.00639	CbGeAlD
Regorafenib—KIT—cardiovascular system—coronary artery disease	0.000274	0.00625	CbGeAlD
Regorafenib—PDGFRA—blood—coronary artery disease	0.000271	0.00618	CbGeAlD
Regorafenib—PDGFRB—cardiovascular system—coronary artery disease	0.000268	0.0061	CbGeAlD
Regorafenib—UGT1A1—blood—coronary artery disease	0.000259	0.0059	CbGeAlD
Regorafenib—ABL1—heart—coronary artery disease	0.000253	0.00576	CbGeAlD
Regorafenib—KDR—blood—coronary artery disease	0.000245	0.00557	CbGeAlD
Regorafenib—PDGFRB—cardiac atrium—coronary artery disease	0.000243	0.00553	CbGeAlD
Regorafenib—ABL1—cardiovascular system—coronary artery disease	0.000239	0.00544	CbGeAlD
Regorafenib—Sorafenib—CYP2C19—coronary artery disease	0.000237	0.0895	CrCbGaD
Regorafenib—KIT—blood—coronary artery disease	0.000217	0.00494	CbGeAlD
Regorafenib—ABL1—cardiac atrium—coronary artery disease	0.000216	0.00493	CbGeAlD
Regorafenib—PDGFRB—blood—coronary artery disease	0.000212	0.00483	CbGeAlD
Regorafenib—ABL1—blood—coronary artery disease	0.000189	0.0043	CbGeAlD
Regorafenib—ABCG2—heart—coronary artery disease	0.00016	0.00363	CbGeAlD
Regorafenib—CYP2B6—heart—coronary artery disease	0.000147	0.00335	CbGeAlD
Regorafenib—CYP2C9—heart—coronary artery disease	0.000146	0.00332	CbGeAlD
Regorafenib—CYP2C19—blood—coronary artery disease	0.00014	0.0032	CbGeAlD
Regorafenib—CYP2B6—cardiovascular system—coronary artery disease	0.000139	0.00316	CbGeAlD
Regorafenib—CYP2C9—cardiovascular system—coronary artery disease	0.000137	0.00313	CbGeAlD
Regorafenib—CYP2C8—blood—coronary artery disease	0.000122	0.00279	CbGeAlD
Regorafenib—ABCG2—blood—coronary artery disease	0.000119	0.00271	CbGeAlD
Regorafenib—CYP2B6—blood—coronary artery disease	0.00011	0.0025	CbGeAlD
Regorafenib—CYP2C9—blood—coronary artery disease	0.000109	0.00248	CbGeAlD
Regorafenib—CYP3A4—blood—coronary artery disease	8.29e-05	0.00189	CbGeAlD
Regorafenib—ABCB1—heart—coronary artery disease	7.87e-05	0.00179	CbGeAlD
Regorafenib—Dry mouth—Losartan—coronary artery disease	7.68e-05	0.000778	CcSEcCtD
Regorafenib—Nervous system disorder—Furosemide—coronary artery disease	7.65e-05	0.000775	CcSEcCtD
Regorafenib—Thrombocytopenia—Furosemide—coronary artery disease	7.64e-05	0.000774	CcSEcCtD
Regorafenib—Pain—Pravastatin—coronary artery disease	7.62e-05	0.000772	CcSEcCtD
Regorafenib—Rash—Acetylsalicylic acid—coronary artery disease	7.62e-05	0.000772	CcSEcCtD
Regorafenib—Gastrointestinal pain—Valsartan—coronary artery disease	7.61e-05	0.000771	CcSEcCtD
Regorafenib—Asthenia—Clopidogrel—coronary artery disease	7.61e-05	0.000771	CcSEcCtD
Regorafenib—Dermatitis—Acetylsalicylic acid—coronary artery disease	7.61e-05	0.000771	CcSEcCtD
Regorafenib—Skin disorder—Furosemide—coronary artery disease	7.58e-05	0.000768	CcSEcCtD
Regorafenib—Gastrointestinal pain—Olmesartan—coronary artery disease	7.58e-05	0.000768	CcSEcCtD
Regorafenib—Asthenia—Lovastatin—coronary artery disease	7.56e-05	0.000766	CcSEcCtD
Regorafenib—Decreased appetite—Trandolapril—coronary artery disease	7.52e-05	0.000762	CcSEcCtD
Regorafenib—Decreased appetite—Enalapril—coronary artery disease	7.49e-05	0.000759	CcSEcCtD
Regorafenib—Infection—Losartan—coronary artery disease	7.48e-05	0.000758	CcSEcCtD
Regorafenib—Angiopathy—Lisinopril—coronary artery disease	7.48e-05	0.000758	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Trandolapril—coronary artery disease	7.47e-05	0.000757	CcSEcCtD
Regorafenib—Fatigue—Trandolapril—coronary artery disease	7.46e-05	0.000756	CcSEcCtD
Regorafenib—Fatigue—Enalapril—coronary artery disease	7.43e-05	0.000753	CcSEcCtD
Regorafenib—Mediastinal disorder—Lisinopril—coronary artery disease	7.43e-05	0.000752	CcSEcCtD
Regorafenib—ABCB1—cardiovascular system—coronary artery disease	7.42e-05	0.00169	CbGeAlD
Regorafenib—Asthenia—Ezetimibe—coronary artery disease	7.42e-05	0.000751	CcSEcCtD
Regorafenib—Tremor—Ramipril—coronary artery disease	7.41e-05	0.000751	CcSEcCtD
Regorafenib—Gastrointestinal pain—Niacin—coronary artery disease	7.4e-05	0.00075	CcSEcCtD
Regorafenib—Decreased appetite—Telmisartan—coronary artery disease	7.39e-05	0.000749	CcSEcCtD
Regorafenib—Nausea—Rosuvastatin—coronary artery disease	7.39e-05	0.000748	CcSEcCtD
Regorafenib—Diarrhoea—Fenofibrate—coronary artery disease	7.39e-05	0.000748	CcSEcCtD
Regorafenib—Nervous system disorder—Losartan—coronary artery disease	7.39e-05	0.000748	CcSEcCtD
Regorafenib—Thrombocytopenia—Losartan—coronary artery disease	7.37e-05	0.000747	CcSEcCtD
Regorafenib—Abdominal pain—Valsartan—coronary artery disease	7.36e-05	0.000746	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Telmisartan—coronary artery disease	7.34e-05	0.000744	CcSEcCtD
Regorafenib—Fatigue—Telmisartan—coronary artery disease	7.33e-05	0.000743	CcSEcCtD
Regorafenib—Body temperature increased—Olmesartan—coronary artery disease	7.33e-05	0.000742	CcSEcCtD
Regorafenib—Abdominal pain—Olmesartan—coronary artery disease	7.33e-05	0.000742	CcSEcCtD
Regorafenib—Gastrointestinal pain—Pravastatin—coronary artery disease	7.29e-05	0.000738	CcSEcCtD
Regorafenib—Alopecia—Lisinopril—coronary artery disease	7.28e-05	0.000738	CcSEcCtD
Regorafenib—Pain—Telmisartan—coronary artery disease	7.27e-05	0.000737	CcSEcCtD
Regorafenib—Diarrhoea—Clopidogrel—coronary artery disease	7.26e-05	0.000735	CcSEcCtD
Regorafenib—Asthenia—Eplerenone—coronary artery disease	7.26e-05	0.000735	CcSEcCtD
Regorafenib—Diarrhoea—Lovastatin—coronary artery disease	7.21e-05	0.000731	CcSEcCtD
Regorafenib—Decreased appetite—Captopril—coronary artery disease	7.19e-05	0.000728	CcSEcCtD
Regorafenib—Nausea—Acetylsalicylic acid—coronary artery disease	7.18e-05	0.000727	CcSEcCtD
Regorafenib—Malnutrition—Lisinopril—coronary artery disease	7.18e-05	0.000727	CcSEcCtD
Regorafenib—Abdominal pain—Niacin—coronary artery disease	7.16e-05	0.000725	CcSEcCtD
Regorafenib—Body temperature increased—Niacin—coronary artery disease	7.16e-05	0.000725	CcSEcCtD
Regorafenib—Fatigue—Captopril—coronary artery disease	7.13e-05	0.000722	CcSEcCtD
Regorafenib—Leukopenia—Ramipril—coronary artery disease	7.08e-05	0.000717	CcSEcCtD
Regorafenib—Gastrointestinal pain—Trandolapril—coronary artery disease	7.08e-05	0.000717	CcSEcCtD
Regorafenib—Asthenia—Simvastatin—coronary artery disease	7.07e-05	0.000717	CcSEcCtD
Regorafenib—Diarrhoea—Ezetimibe—coronary artery disease	7.07e-05	0.000717	CcSEcCtD
Regorafenib—Gastrointestinal pain—Enalapril—coronary artery disease	7.05e-05	0.000714	CcSEcCtD
Regorafenib—Abdominal pain—Pravastatin—coronary artery disease	7.05e-05	0.000714	CcSEcCtD
Regorafenib—Body temperature increased—Pravastatin—coronary artery disease	7.05e-05	0.000714	CcSEcCtD
Regorafenib—Decreased appetite—Perindopril—coronary artery disease	6.98e-05	0.000707	CcSEcCtD
Regorafenib—Gastrointestinal pain—Telmisartan—coronary artery disease	6.95e-05	0.000704	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Perindopril—coronary artery disease	6.93e-05	0.000702	CcSEcCtD
Regorafenib—Diarrhoea—Eplerenone—coronary artery disease	6.92e-05	0.000701	CcSEcCtD
Regorafenib—Fatigue—Perindopril—coronary artery disease	6.92e-05	0.000701	CcSEcCtD
Regorafenib—Pain—Perindopril—coronary artery disease	6.87e-05	0.000695	CcSEcCtD
Regorafenib—Vomiting—Fenofibrate—coronary artery disease	6.86e-05	0.000695	CcSEcCtD
Regorafenib—Abdominal pain—Trandolapril—coronary artery disease	6.84e-05	0.000693	CcSEcCtD
Regorafenib—Body temperature increased—Trandolapril—coronary artery disease	6.84e-05	0.000693	CcSEcCtD
Regorafenib—Abdominal pain—Enalapril—coronary artery disease	6.82e-05	0.00069	CcSEcCtD
Regorafenib—Body temperature increased—Enalapril—coronary artery disease	6.82e-05	0.00069	CcSEcCtD
Regorafenib—Rash—Fenofibrate—coronary artery disease	6.81e-05	0.000689	CcSEcCtD
Regorafenib—Dermatitis—Fenofibrate—coronary artery disease	6.8e-05	0.000689	CcSEcCtD
Regorafenib—Decreased appetite—Furosemide—coronary artery disease	6.78e-05	0.000687	CcSEcCtD
Regorafenib—Headache—Fenofibrate—coronary artery disease	6.76e-05	0.000685	CcSEcCtD
Regorafenib—Gastrointestinal pain—Captopril—coronary artery disease	6.76e-05	0.000685	CcSEcCtD
Regorafenib—Vomiting—Clopidogrel—coronary artery disease	6.75e-05	0.000683	CcSEcCtD
Regorafenib—Diarrhoea—Simvastatin—coronary artery disease	6.75e-05	0.000683	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Furosemide—coronary artery disease	6.74e-05	0.000683	CcSEcCtD
Regorafenib—Fatigue—Furosemide—coronary artery disease	6.73e-05	0.000682	CcSEcCtD
Regorafenib—Tremor—Lisinopril—coronary artery disease	6.72e-05	0.000681	CcSEcCtD
Regorafenib—Abdominal pain—Telmisartan—coronary artery disease	6.72e-05	0.000681	CcSEcCtD
Regorafenib—Body temperature increased—Telmisartan—coronary artery disease	6.72e-05	0.000681	CcSEcCtD
Regorafenib—Vomiting—Lovastatin—coronary artery disease	6.7e-05	0.000679	CcSEcCtD
Regorafenib—Rash—Clopidogrel—coronary artery disease	6.69e-05	0.000678	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	6.69e-05	0.000678	CcSEcCtD
Regorafenib—Dermatitis—Clopidogrel—coronary artery disease	6.68e-05	0.000677	CcSEcCtD
Regorafenib—Asthenia—Valsartan—coronary artery disease	6.68e-05	0.000677	CcSEcCtD
Regorafenib—Hypertension—Timolol—coronary artery disease	6.68e-05	0.000676	CcSEcCtD
Regorafenib—Pain—Furosemide—coronary artery disease	6.67e-05	0.000676	CcSEcCtD
Regorafenib—Asthenia—Olmesartan—coronary artery disease	6.65e-05	0.000673	CcSEcCtD
Regorafenib—Headache—Clopidogrel—coronary artery disease	6.65e-05	0.000673	CcSEcCtD
Regorafenib—Rash—Lovastatin—coronary artery disease	6.65e-05	0.000673	CcSEcCtD
Regorafenib—Dermatitis—Lovastatin—coronary artery disease	6.64e-05	0.000673	CcSEcCtD
Regorafenib—Anaemia—Lisinopril—coronary artery disease	6.63e-05	0.000672	CcSEcCtD
Regorafenib—Headache—Lovastatin—coronary artery disease	6.6e-05	0.000669	CcSEcCtD
Regorafenib—Dry mouth—Ramipril—coronary artery disease	6.59e-05	0.000667	CcSEcCtD
Regorafenib—Vomiting—Ezetimibe—coronary artery disease	6.57e-05	0.000666	CcSEcCtD
Regorafenib—Gastrointestinal pain—Perindopril—coronary artery disease	6.57e-05	0.000665	CcSEcCtD
Regorafenib—Decreased appetite—Losartan—coronary artery disease	6.55e-05	0.000663	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	6.54e-05	0.000662	CcSEcCtD
Regorafenib—Body temperature increased—Captopril—coronary artery disease	6.54e-05	0.000662	CcSEcCtD
Regorafenib—Abdominal pain—Captopril—coronary artery disease	6.54e-05	0.000662	CcSEcCtD
Regorafenib—Rash—Ezetimibe—coronary artery disease	6.52e-05	0.00066	CcSEcCtD
Regorafenib—Dermatitis—Ezetimibe—coronary artery disease	6.51e-05	0.00066	CcSEcCtD
Regorafenib—Asthenia—Niacin—coronary artery disease	6.5e-05	0.000658	CcSEcCtD
Regorafenib—Fatigue—Losartan—coronary artery disease	6.49e-05	0.000658	CcSEcCtD
Regorafenib—Headache—Ezetimibe—coronary artery disease	6.48e-05	0.000656	CcSEcCtD
Regorafenib—Dry mouth—Timolol—coronary artery disease	6.44e-05	0.000652	CcSEcCtD
Regorafenib—Pain—Losartan—coronary artery disease	6.44e-05	0.000652	CcSEcCtD
Regorafenib—Vomiting—Eplerenone—coronary artery disease	6.43e-05	0.000652	CcSEcCtD
Regorafenib—Leukopenia—Lisinopril—coronary artery disease	6.42e-05	0.000651	CcSEcCtD
Regorafenib—Nausea—Fenofibrate—coronary artery disease	6.41e-05	0.00065	CcSEcCtD
Regorafenib—Asthenia—Pravastatin—coronary artery disease	6.4e-05	0.000648	CcSEcCtD
Regorafenib—Gastrointestinal pain—Furosemide—coronary artery disease	6.38e-05	0.000646	CcSEcCtD
Regorafenib—Rash—Eplerenone—coronary artery disease	6.38e-05	0.000646	CcSEcCtD
Regorafenib—Dermatitis—Eplerenone—coronary artery disease	6.37e-05	0.000646	CcSEcCtD
Regorafenib—Diarrhoea—Valsartan—coronary artery disease	6.37e-05	0.000645	CcSEcCtD
Regorafenib—Abdominal pain—Perindopril—coronary artery disease	6.35e-05	0.000643	CcSEcCtD
Regorafenib—Body temperature increased—Perindopril—coronary artery disease	6.35e-05	0.000643	CcSEcCtD
Regorafenib—Diarrhoea—Olmesartan—coronary artery disease	6.34e-05	0.000642	CcSEcCtD
Regorafenib—Headache—Eplerenone—coronary artery disease	6.34e-05	0.000642	CcSEcCtD
Regorafenib—Nervous system disorder—Ramipril—coronary artery disease	6.33e-05	0.000641	CcSEcCtD
Regorafenib—Thrombocytopenia—Ramipril—coronary artery disease	6.32e-05	0.00064	CcSEcCtD
Regorafenib—Nausea—Clopidogrel—coronary artery disease	6.3e-05	0.000638	CcSEcCtD
Regorafenib—Skin disorder—Ramipril—coronary artery disease	6.27e-05	0.000635	CcSEcCtD
Regorafenib—Infection—Timolol—coronary artery disease	6.27e-05	0.000635	CcSEcCtD
Regorafenib—Vomiting—Simvastatin—coronary artery disease	6.27e-05	0.000635	CcSEcCtD
Regorafenib—Nausea—Lovastatin—coronary artery disease	6.26e-05	0.000634	CcSEcCtD
Regorafenib—Rash—Simvastatin—coronary artery disease	6.22e-05	0.00063	CcSEcCtD
Regorafenib—Dermatitis—Simvastatin—coronary artery disease	6.21e-05	0.000629	CcSEcCtD
Regorafenib—Asthenia—Trandolapril—coronary artery disease	6.21e-05	0.000629	CcSEcCtD
Regorafenib—Diarrhoea—Niacin—coronary artery disease	6.19e-05	0.000627	CcSEcCtD
Regorafenib—Nervous system disorder—Timolol—coronary artery disease	6.19e-05	0.000627	CcSEcCtD
Regorafenib—Asthenia—Enalapril—coronary artery disease	6.19e-05	0.000627	CcSEcCtD
Regorafenib—Headache—Simvastatin—coronary artery disease	6.18e-05	0.000626	CcSEcCtD
Regorafenib—Abdominal pain—Furosemide—coronary artery disease	6.17e-05	0.000625	CcSEcCtD
Regorafenib—Body temperature increased—Furosemide—coronary artery disease	6.17e-05	0.000625	CcSEcCtD
Regorafenib—Gastrointestinal pain—Losartan—coronary artery disease	6.16e-05	0.000624	CcSEcCtD
Regorafenib—Nausea—Ezetimibe—coronary artery disease	6.14e-05	0.000622	CcSEcCtD
Regorafenib—Skin disorder—Timolol—coronary artery disease	6.13e-05	0.000621	CcSEcCtD
Regorafenib—Asthenia—Telmisartan—coronary artery disease	6.1e-05	0.000618	CcSEcCtD
Regorafenib—Diarrhoea—Pravastatin—coronary artery disease	6.1e-05	0.000618	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.07e-05	0.000615	CcSEcCtD
Regorafenib—Nausea—Eplerenone—coronary artery disease	6.01e-05	0.000609	CcSEcCtD
Regorafenib—Dry mouth—Lisinopril—coronary artery disease	5.97e-05	0.000605	CcSEcCtD
Regorafenib—Body temperature increased—Losartan—coronary artery disease	5.95e-05	0.000603	CcSEcCtD
Regorafenib—Abdominal pain—Losartan—coronary artery disease	5.95e-05	0.000603	CcSEcCtD
Regorafenib—Asthenia—Captopril—coronary artery disease	5.93e-05	0.000601	CcSEcCtD
Regorafenib—Diarrhoea—Trandolapril—coronary artery disease	5.92e-05	0.0006	CcSEcCtD
Regorafenib—Vomiting—Valsartan—coronary artery disease	5.92e-05	0.0006	CcSEcCtD
Regorafenib—Diarrhoea—Enalapril—coronary artery disease	5.9e-05	0.000598	CcSEcCtD
Regorafenib—Vomiting—Olmesartan—coronary artery disease	5.89e-05	0.000597	CcSEcCtD
Regorafenib—Rash—Valsartan—coronary artery disease	5.87e-05	0.000595	CcSEcCtD
Regorafenib—ABCB1—blood—coronary artery disease	5.87e-05	0.00134	CbGeAlD
Regorafenib—Dermatitis—Valsartan—coronary artery disease	5.87e-05	0.000594	CcSEcCtD
Regorafenib—Nausea—Simvastatin—coronary artery disease	5.86e-05	0.000593	CcSEcCtD
Regorafenib—Rash—Olmesartan—coronary artery disease	5.84e-05	0.000592	CcSEcCtD
Regorafenib—Dermatitis—Olmesartan—coronary artery disease	5.84e-05	0.000591	CcSEcCtD
Regorafenib—Headache—Valsartan—coronary artery disease	5.83e-05	0.000591	CcSEcCtD
Regorafenib—Diarrhoea—Telmisartan—coronary artery disease	5.82e-05	0.000589	CcSEcCtD
Regorafenib—Infection—Lisinopril—coronary artery disease	5.82e-05	0.000589	CcSEcCtD
Regorafenib—Headache—Olmesartan—coronary artery disease	5.81e-05	0.000588	CcSEcCtD
Regorafenib—Asthenia—Perindopril—coronary artery disease	5.76e-05	0.000583	CcSEcCtD
Regorafenib—Vomiting—Niacin—coronary artery disease	5.76e-05	0.000583	CcSEcCtD
Regorafenib—Thrombocytopenia—Lisinopril—coronary artery disease	5.73e-05	0.000581	CcSEcCtD
Regorafenib—Rash—Niacin—coronary artery disease	5.71e-05	0.000578	CcSEcCtD
Regorafenib—Dermatitis—Niacin—coronary artery disease	5.7e-05	0.000578	CcSEcCtD
Regorafenib—Skin disorder—Lisinopril—coronary artery disease	5.69e-05	0.000576	CcSEcCtD
Regorafenib—Headache—Niacin—coronary artery disease	5.67e-05	0.000575	CcSEcCtD
Regorafenib—Vomiting—Pravastatin—coronary artery disease	5.67e-05	0.000574	CcSEcCtD
Regorafenib—Diarrhoea—Captopril—coronary artery disease	5.66e-05	0.000573	CcSEcCtD
Regorafenib—Rash—Pravastatin—coronary artery disease	5.62e-05	0.000569	CcSEcCtD
Regorafenib—Dermatitis—Pravastatin—coronary artery disease	5.62e-05	0.000569	CcSEcCtD
Regorafenib—Decreased appetite—Ramipril—coronary artery disease	5.61e-05	0.000569	CcSEcCtD
Regorafenib—Asthenia—Furosemide—coronary artery disease	5.6e-05	0.000567	CcSEcCtD
Regorafenib—Headache—Pravastatin—coronary artery disease	5.58e-05	0.000566	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Ramipril—coronary artery disease	5.57e-05	0.000565	CcSEcCtD
Regorafenib—Fatigue—Ramipril—coronary artery disease	5.57e-05	0.000564	CcSEcCtD
Regorafenib—Nausea—Valsartan—coronary artery disease	5.53e-05	0.00056	CcSEcCtD
Regorafenib—Nausea—Olmesartan—coronary artery disease	5.5e-05	0.000558	CcSEcCtD
Regorafenib—Vomiting—Trandolapril—coronary artery disease	5.5e-05	0.000558	CcSEcCtD
Regorafenib—Diarrhoea—Perindopril—coronary artery disease	5.49e-05	0.000556	CcSEcCtD
Regorafenib—Decreased appetite—Timolol—coronary artery disease	5.49e-05	0.000556	CcSEcCtD
Regorafenib—Vomiting—Enalapril—coronary artery disease	5.48e-05	0.000555	CcSEcCtD
Regorafenib—Rash—Trandolapril—coronary artery disease	5.46e-05	0.000553	CcSEcCtD
Regorafenib—Dermatitis—Trandolapril—coronary artery disease	5.45e-05	0.000552	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Timolol—coronary artery disease	5.45e-05	0.000552	CcSEcCtD
Regorafenib—Fatigue—Timolol—coronary artery disease	5.44e-05	0.000551	CcSEcCtD
Regorafenib—Rash—Enalapril—coronary artery disease	5.44e-05	0.000551	CcSEcCtD
Regorafenib—Dermatitis—Enalapril—coronary artery disease	5.43e-05	0.00055	CcSEcCtD
Regorafenib—Headache—Trandolapril—coronary artery disease	5.42e-05	0.000549	CcSEcCtD
Regorafenib—Vomiting—Telmisartan—coronary artery disease	5.41e-05	0.000548	CcSEcCtD
Regorafenib—Asthenia—Losartan—coronary artery disease	5.4e-05	0.000547	CcSEcCtD
Regorafenib—Headache—Enalapril—coronary artery disease	5.4e-05	0.000547	CcSEcCtD
Regorafenib—Pain—Timolol—coronary artery disease	5.4e-05	0.000547	CcSEcCtD
Regorafenib—Nausea—Niacin—coronary artery disease	5.38e-05	0.000545	CcSEcCtD
Regorafenib—Rash—Telmisartan—coronary artery disease	5.36e-05	0.000543	CcSEcCtD
Regorafenib—Dermatitis—Telmisartan—coronary artery disease	5.36e-05	0.000543	CcSEcCtD
Regorafenib—Diarrhoea—Furosemide—coronary artery disease	5.34e-05	0.000541	CcSEcCtD
Regorafenib—Headache—Telmisartan—coronary artery disease	5.33e-05	0.00054	CcSEcCtD
Regorafenib—Nausea—Pravastatin—coronary artery disease	5.29e-05	0.000536	CcSEcCtD
Regorafenib—Gastrointestinal pain—Ramipril—coronary artery disease	5.28e-05	0.000535	CcSEcCtD
Regorafenib—Vomiting—Captopril—coronary artery disease	5.26e-05	0.000533	CcSEcCtD
Regorafenib—Rash—Captopril—coronary artery disease	5.21e-05	0.000528	CcSEcCtD
Regorafenib—Dermatitis—Captopril—coronary artery disease	5.21e-05	0.000528	CcSEcCtD
Regorafenib—Headache—Captopril—coronary artery disease	5.18e-05	0.000525	CcSEcCtD
Regorafenib—Gastrointestinal pain—Timolol—coronary artery disease	5.16e-05	0.000523	CcSEcCtD
Regorafenib—Diarrhoea—Losartan—coronary artery disease	5.15e-05	0.000522	CcSEcCtD
Regorafenib—Nausea—Trandolapril—coronary artery disease	5.14e-05	0.000521	CcSEcCtD
Regorafenib—Nausea—Enalapril—coronary artery disease	5.12e-05	0.000519	CcSEcCtD
Regorafenib—Vomiting—Perindopril—coronary artery disease	5.1e-05	0.000517	CcSEcCtD
Regorafenib—Abdominal pain—Ramipril—coronary artery disease	5.1e-05	0.000517	CcSEcCtD
Regorafenib—Body temperature increased—Ramipril—coronary artery disease	5.1e-05	0.000517	CcSEcCtD
Regorafenib—Decreased appetite—Lisinopril—coronary artery disease	5.09e-05	0.000516	CcSEcCtD
Regorafenib—Rash—Perindopril—coronary artery disease	5.06e-05	0.000513	CcSEcCtD
Regorafenib—Dermatitis—Perindopril—coronary artery disease	5.06e-05	0.000512	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.06e-05	0.000512	CcSEcCtD
Regorafenib—Nausea—Telmisartan—coronary artery disease	5.05e-05	0.000512	CcSEcCtD
Regorafenib—Fatigue—Lisinopril—coronary artery disease	5.05e-05	0.000511	CcSEcCtD
Regorafenib—Headache—Perindopril—coronary artery disease	5.03e-05	0.000509	CcSEcCtD
Regorafenib—Pain—Lisinopril—coronary artery disease	5.01e-05	0.000507	CcSEcCtD
Regorafenib—Body temperature increased—Timolol—coronary artery disease	4.99e-05	0.000505	CcSEcCtD
Regorafenib—Abdominal pain—Timolol—coronary artery disease	4.99e-05	0.000505	CcSEcCtD
Regorafenib—Vomiting—Furosemide—coronary artery disease	4.96e-05	0.000503	CcSEcCtD
Regorafenib—Rash—Furosemide—coronary artery disease	4.92e-05	0.000498	CcSEcCtD
Regorafenib—Dermatitis—Furosemide—coronary artery disease	4.92e-05	0.000498	CcSEcCtD
Regorafenib—Nausea—Captopril—coronary artery disease	4.91e-05	0.000498	CcSEcCtD
Regorafenib—Headache—Furosemide—coronary artery disease	4.89e-05	0.000495	CcSEcCtD
Regorafenib—Gastrointestinal pain—Lisinopril—coronary artery disease	4.79e-05	0.000485	CcSEcCtD
Regorafenib—Vomiting—Losartan—coronary artery disease	4.79e-05	0.000485	CcSEcCtD
Regorafenib—Nausea—Perindopril—coronary artery disease	4.77e-05	0.000483	CcSEcCtD
Regorafenib—Rash—Losartan—coronary artery disease	4.75e-05	0.000481	CcSEcCtD
Regorafenib—Dermatitis—Losartan—coronary artery disease	4.74e-05	0.000481	CcSEcCtD
Regorafenib—Headache—Losartan—coronary artery disease	4.72e-05	0.000478	CcSEcCtD
Regorafenib—Nausea—Furosemide—coronary artery disease	4.64e-05	0.00047	CcSEcCtD
Regorafenib—Asthenia—Ramipril—coronary artery disease	4.63e-05	0.000469	CcSEcCtD
Regorafenib—Abdominal pain—Lisinopril—coronary artery disease	4.63e-05	0.000469	CcSEcCtD
Regorafenib—Body temperature increased—Lisinopril—coronary artery disease	4.63e-05	0.000469	CcSEcCtD
Regorafenib—Asthenia—Timolol—coronary artery disease	4.53e-05	0.000459	CcSEcCtD
Regorafenib—Nausea—Losartan—coronary artery disease	4.47e-05	0.000453	CcSEcCtD
Regorafenib—Diarrhoea—Ramipril—coronary artery disease	4.42e-05	0.000448	CcSEcCtD
Regorafenib—Diarrhoea—Timolol—coronary artery disease	4.32e-05	0.000438	CcSEcCtD
Regorafenib—Asthenia—Lisinopril—coronary artery disease	4.2e-05	0.000426	CcSEcCtD
Regorafenib—Vomiting—Ramipril—coronary artery disease	4.11e-05	0.000416	CcSEcCtD
Regorafenib—Rash—Ramipril—coronary artery disease	4.07e-05	0.000412	CcSEcCtD
Regorafenib—Dermatitis—Ramipril—coronary artery disease	4.07e-05	0.000412	CcSEcCtD
Regorafenib—Headache—Ramipril—coronary artery disease	4.05e-05	0.00041	CcSEcCtD
Regorafenib—Vomiting—Timolol—coronary artery disease	4.01e-05	0.000407	CcSEcCtD
Regorafenib—Diarrhoea—Lisinopril—coronary artery disease	4.01e-05	0.000406	CcSEcCtD
Regorafenib—Rash—Timolol—coronary artery disease	3.98e-05	0.000403	CcSEcCtD
Regorafenib—Dermatitis—Timolol—coronary artery disease	3.98e-05	0.000403	CcSEcCtD
Regorafenib—Headache—Timolol—coronary artery disease	3.95e-05	0.000401	CcSEcCtD
Regorafenib—Nausea—Ramipril—coronary artery disease	3.84e-05	0.000389	CcSEcCtD
Regorafenib—Nausea—Timolol—coronary artery disease	3.75e-05	0.00038	CcSEcCtD
Regorafenib—Vomiting—Lisinopril—coronary artery disease	3.72e-05	0.000377	CcSEcCtD
Regorafenib—Rash—Lisinopril—coronary artery disease	3.69e-05	0.000374	CcSEcCtD
Regorafenib—Dermatitis—Lisinopril—coronary artery disease	3.69e-05	0.000374	CcSEcCtD
Regorafenib—Headache—Lisinopril—coronary artery disease	3.67e-05	0.000372	CcSEcCtD
Regorafenib—Nausea—Lisinopril—coronary artery disease	3.48e-05	0.000352	CcSEcCtD
Regorafenib—FGFR1—Signaling Pathways—CCND1—coronary artery disease	5.74e-07	4.5e-06	CbGpPWpGaD
Regorafenib—MAPK11—Gene Expression—AKT1—coronary artery disease	5.74e-07	4.49e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—LPL—coronary artery disease	5.74e-07	4.49e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—CCND1—coronary artery disease	5.73e-07	4.48e-06	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—coronary artery disease	5.73e-07	4.48e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—APOE—coronary artery disease	5.68e-07	4.45e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GSTP1—coronary artery disease	5.68e-07	4.44e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—FGF2—coronary artery disease	5.65e-07	4.42e-06	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—coronary artery disease	5.65e-07	4.42e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	5.63e-07	4.4e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—PIK3CA—coronary artery disease	5.63e-07	4.4e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—APOA1—coronary artery disease	5.62e-07	4.4e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—HMOX1—coronary artery disease	5.6e-07	4.38e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—GPX1—coronary artery disease	5.6e-07	4.38e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PIK3CA—coronary artery disease	5.59e-07	4.37e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—MAPK1—coronary artery disease	5.58e-07	4.37e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MMP9—coronary artery disease	5.58e-07	4.36e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PIK3CA—coronary artery disease	5.57e-07	4.36e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—NOS3—coronary artery disease	5.57e-07	4.36e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MMP9—coronary artery disease	5.56e-07	4.35e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GSTP1—coronary artery disease	5.54e-07	4.34e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CXCL8—coronary artery disease	5.54e-07	4.34e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—VCAN—coronary artery disease	5.53e-07	4.33e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CAT—coronary artery disease	5.53e-07	4.32e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARGC1A—coronary artery disease	5.49e-07	4.3e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALDOA—coronary artery disease	5.49e-07	4.29e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—HMOX1—coronary artery disease	5.47e-07	4.28e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CD36—coronary artery disease	5.45e-07	4.27e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—PIK3CA—coronary artery disease	5.44e-07	4.25e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—JAK2—coronary artery disease	5.41e-07	4.23e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CAT—coronary artery disease	5.39e-07	4.22e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPP2CA—coronary artery disease	5.39e-07	4.21e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—VEGFA—coronary artery disease	5.37e-07	4.2e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—TGFB1—coronary artery disease	5.37e-07	4.2e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOB—coronary artery disease	5.37e-07	4.2e-06	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—coronary artery disease	5.36e-07	4.19e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—coronary artery disease	5.34e-07	4.18e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DCN—coronary artery disease	5.33e-07	4.17e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—TGFB1—coronary artery disease	5.32e-07	4.16e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—PIK3CA—coronary artery disease	5.32e-07	4.16e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PTGS2—coronary artery disease	5.31e-07	4.16e-06	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—coronary artery disease	5.31e-07	4.15e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—PIK3CA—coronary artery disease	5.3e-07	4.15e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CASP3—coronary artery disease	5.3e-07	4.15e-06	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—AKT1—coronary artery disease	5.3e-07	4.15e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—PIK3CA—coronary artery disease	5.3e-07	4.15e-06	CbGpPWpGaD
Regorafenib—BRAF—Disease—AKT1—coronary artery disease	5.28e-07	4.13e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—VEGFA—coronary artery disease	5.28e-07	4.13e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—MAPK1—coronary artery disease	5.27e-07	4.12e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—TGFB1—coronary artery disease	5.26e-07	4.11e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOB—coronary artery disease	5.24e-07	4.1e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GSTM1—coronary artery disease	5.22e-07	4.08e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—MAPK1—coronary artery disease	5.22e-07	4.08e-06	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—coronary artery disease	5.21e-07	4.08e-06	CbGpPWpGaD
Regorafenib—KIT—Immune System—AKT1—coronary artery disease	5.21e-07	4.08e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.18e-07	4.05e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GSTP1—coronary artery disease	5.18e-07	4.05e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—MTHFR—coronary artery disease	5.17e-07	4.04e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—CCND1—coronary artery disease	5.16e-07	4.04e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—MAPK1—coronary artery disease	5.16e-07	4.03e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	5.13e-07	4.02e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—LPL—coronary artery disease	5.12e-07	4.01e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—HMOX1—coronary artery disease	5.11e-07	4e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GSTM1—coronary artery disease	5.09e-07	3.99e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—LIPC—coronary artery disease	5.05e-07	3.95e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HBA1—coronary artery disease	5.05e-07	3.95e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CYP2C19—coronary artery disease	5.05e-07	3.95e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	5.05e-07	3.95e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CAT—coronary artery disease	5.04e-07	3.94e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PIK3CA—coronary artery disease	5.02e-07	3.93e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOC3—coronary artery disease	5.02e-07	3.93e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MMP9—coronary artery disease	5.01e-07	3.92e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—VEGFA—coronary artery disease	5.01e-07	3.92e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—LPL—coronary artery disease	5e-07	3.91e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—GPX1—coronary artery disease	5e-07	3.91e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—VEGFA—coronary artery disease	5e-07	3.91e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—LDLR—coronary artery disease	4.99e-07	3.9e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—coronary artery disease	4.98e-07	3.9e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PPARG—coronary artery disease	4.95e-07	3.87e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—coronary artery disease	4.95e-07	3.87e-06	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—AKT1—coronary artery disease	4.94e-07	3.87e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CXCL8—coronary artery disease	4.94e-07	3.86e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—coronary artery disease	4.93e-07	3.86e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—TGFB1—coronary artery disease	4.93e-07	3.86e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—AKT1—coronary artery disease	4.93e-07	3.86e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTT1—coronary artery disease	4.93e-07	3.86e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC9A1—coronary artery disease	4.93e-07	3.86e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AGT—coronary artery disease	4.91e-07	3.84e-06	CbGpPWpGaD
Regorafenib—FGFR2—Disease—AKT1—coronary artery disease	4.9e-07	3.83e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOB—coronary artery disease	4.89e-07	3.83e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—coronary artery disease	4.88e-07	3.82e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—GPX1—coronary artery disease	4.88e-07	3.82e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GCLC—coronary artery disease	4.87e-07	3.81e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CETP—coronary artery disease	4.87e-07	3.81e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CD36—coronary artery disease	4.87e-07	3.81e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—PIK3CA—coronary artery disease	4.85e-07	3.79e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—TGFB1—coronary artery disease	4.84e-07	3.79e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—MAPK1—coronary artery disease	4.84e-07	3.78e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SDC1—coronary artery disease	4.82e-07	3.77e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—coronary artery disease	4.81e-07	3.77e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOE—coronary artery disease	4.81e-07	3.76e-06	CbGpPWpGaD
Regorafenib—KIT—Disease—AKT1—coronary artery disease	4.81e-07	3.76e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPP2CA—coronary artery disease	4.81e-07	3.76e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GSTM1—coronary artery disease	4.76e-07	3.72e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—APOA1—coronary artery disease	4.76e-07	3.72e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CD36—coronary artery disease	4.75e-07	3.72e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—MAPK1—coronary artery disease	4.75e-07	3.72e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CASP3—coronary artery disease	4.73e-07	3.7e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—coronary artery disease	4.71e-07	3.68e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—coronary artery disease	4.7e-07	3.68e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPP2CA—coronary artery disease	4.69e-07	3.67e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—coronary artery disease	4.69e-07	3.67e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—LPL—coronary artery disease	4.67e-07	3.66e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—MTHFR—coronary artery disease	4.61e-07	3.61e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—CCND1—coronary artery disease	4.6e-07	3.6e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—TGFB1—coronary artery disease	4.6e-07	3.6e-06	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—AKT1—coronary artery disease	4.6e-07	3.6e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—TGFB1—coronary artery disease	4.58e-07	3.59e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—PIK3CA—coronary artery disease	4.57e-07	3.58e-06	CbGpPWpGaD
Regorafenib—FGFR1—Disease—AKT1—coronary artery disease	4.56e-07	3.57e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—GPX1—coronary artery disease	4.56e-07	3.57e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.55e-07	3.56e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—AKT1—coronary artery disease	4.55e-07	3.56e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PSMA6—coronary artery disease	4.55e-07	3.56e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PSMB5—coronary artery disease	4.55e-07	3.56e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—PIK3CA—coronary artery disease	4.53e-07	3.54e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—MAPK1—coronary artery disease	4.51e-07	3.53e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—MTHFR—coronary artery disease	4.5e-07	3.52e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—VEGFA—coronary artery disease	4.5e-07	3.52e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—MAPK1—coronary artery disease	4.5e-07	3.52e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—PIK3CA—coronary artery disease	4.47e-07	3.5e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MMP9—coronary artery disease	4.47e-07	3.5e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ALB—coronary artery disease	4.45e-07	3.48e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—coronary artery disease	4.44e-07	3.48e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CTGF—coronary artery disease	4.44e-07	3.48e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—AKT1—coronary artery disease	4.44e-07	3.48e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CD36—coronary artery disease	4.44e-07	3.47e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.4e-07	3.45e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT2—coronary artery disease	4.4e-07	3.45e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPP2CA—coronary artery disease	4.38e-07	3.43e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AGT—coronary artery disease	4.38e-07	3.43e-06	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—AKT1—coronary artery disease	4.34e-07	3.4e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—AKT1—coronary artery disease	4.33e-07	3.39e-06	CbGpPWpGaD
Regorafenib—ABL1—Immune System—AKT1—coronary artery disease	4.33e-07	3.39e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOE—coronary artery disease	4.29e-07	3.36e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—coronary artery disease	4.29e-07	3.36e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AGT—coronary artery disease	4.28e-07	3.35e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—NOS3—coronary artery disease	4.26e-07	3.33e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—APOA1—coronary artery disease	4.25e-07	3.32e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—MTHFR—coronary artery disease	4.21e-07	3.29e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—PIK3CA—coronary artery disease	4.2e-07	3.28e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOE—coronary artery disease	4.19e-07	3.28e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PPARG—coronary artery disease	4.19e-07	3.28e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—APOA1—coronary artery disease	4.14e-07	3.24e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—coronary artery disease	4.13e-07	3.23e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—TGFB1—coronary artery disease	4.13e-07	3.23e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—PIK3CA—coronary artery disease	4.12e-07	3.23e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—AKT1—coronary artery disease	4.1e-07	3.21e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.06e-07	3.18e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—MAPK1—coronary artery disease	4.05e-07	3.17e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.05e-07	3.17e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—coronary artery disease	4.05e-07	3.17e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—VEGFA—coronary artery disease	4.01e-07	3.14e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—coronary artery disease	4.01e-07	3.14e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AGT—coronary artery disease	4e-07	3.13e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—coronary artery disease	3.96e-07	3.1e-06	CbGpPWpGaD
Regorafenib—RAF1—Immune System—AKT1—coronary artery disease	3.96e-07	3.1e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ABCA1—coronary artery disease	3.93e-07	3.07e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOE—coronary artery disease	3.92e-07	3.06e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—PIK3CA—coronary artery disease	3.91e-07	3.06e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—PIK3CA—coronary artery disease	3.9e-07	3.05e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PTGS2—coronary artery disease	3.89e-07	3.05e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—APOA1—coronary artery disease	3.87e-07	3.03e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PIK3CA—coronary artery disease	3.85e-07	3.01e-06	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PIK3CA—coronary artery disease	3.85e-07	3.01e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GOT1—coronary artery disease	3.8e-07	2.98e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GGT1—coronary artery disease	3.8e-07	2.98e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ALB—coronary artery disease	3.77e-07	2.95e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PPARG—coronary artery disease	3.74e-07	2.93e-06	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—AKT1—coronary artery disease	3.73e-07	2.92e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—coronary artery disease	3.72e-07	2.91e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.71e-07	2.9e-06	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—AKT1—coronary artery disease	3.7e-07	2.89e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—coronary artery disease	3.69e-07	2.89e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—TGFB1—coronary artery disease	3.68e-07	2.88e-06	CbGpPWpGaD
Regorafenib—RAF1—Disease—AKT1—coronary artery disease	3.65e-07	2.86e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PPARG—coronary artery disease	3.65e-07	2.86e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—coronary artery disease	3.65e-07	2.86e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—MAPK1—coronary artery disease	3.61e-07	2.83e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—NOS3—coronary artery disease	3.6e-07	2.82e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—coronary artery disease	3.6e-07	2.82e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—PIK3CA—coronary artery disease	3.52e-07	2.75e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—coronary artery disease	3.46e-07	2.71e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—coronary artery disease	3.45e-07	2.7e-06	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—AKT1—coronary artery disease	3.43e-07	2.68e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.42e-07	2.67e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PPARG—coronary artery disease	3.41e-07	2.67e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.38e-07	2.65e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.37e-07	2.64e-06	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—AKT1—coronary artery disease	3.37e-07	2.63e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—coronary artery disease	3.36e-07	2.63e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ALB—coronary artery disease	3.36e-07	2.63e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CAT—coronary artery disease	3.32e-07	2.6e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PTGS2—coronary artery disease	3.3e-07	2.58e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ALB—coronary artery disease	3.28e-07	2.57e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PIK3CA—coronary artery disease	3.27e-07	2.56e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOB—coronary artery disease	3.23e-07	2.52e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—NOS3—coronary artery disease	3.22e-07	2.52e-06	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—AKT1—coronary artery disease	3.2e-07	2.5e-06	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—AKT1—coronary artery disease	3.19e-07	2.49e-06	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—AKT1—coronary artery disease	3.15e-07	2.46e-06	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—AKT1—coronary artery disease	3.15e-07	2.46e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—NOS3—coronary artery disease	3.14e-07	2.46e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.14e-07	2.46e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—PIK3CA—coronary artery disease	3.13e-07	2.45e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—coronary artery disease	3.11e-07	2.44e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—LPL—coronary artery disease	3.08e-07	2.41e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ALB—coronary artery disease	3.07e-07	2.4e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—GPX1—coronary artery disease	3.01e-07	2.35e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PTGS2—coronary artery disease	2.94e-07	2.3e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—NOS3—coronary artery disease	2.93e-07	2.3e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CD36—coronary artery disease	2.93e-07	2.29e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPP2CA—coronary artery disease	2.89e-07	2.26e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PTGS2—coronary artery disease	2.87e-07	2.25e-06	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—AKT1—coronary artery disease	2.87e-07	2.25e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—coronary artery disease	2.77e-07	2.17e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—MTHFR—coronary artery disease	2.77e-07	2.17e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PTGS2—coronary artery disease	2.68e-07	2.1e-06	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—AKT1—coronary artery disease	2.67e-07	2.09e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AGT—coronary artery disease	2.64e-07	2.06e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOE—coronary artery disease	2.58e-07	2.02e-06	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—AKT1—coronary artery disease	2.56e-07	2e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—APOA1—coronary artery disease	2.55e-07	2e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PIK3CA—coronary artery disease	2.4e-07	1.87e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PPARG—coronary artery disease	2.25e-07	1.76e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—coronary artery disease	2.22e-07	1.74e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PIK3CA—coronary artery disease	2.03e-07	1.59e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ALB—coronary artery disease	2.02e-07	1.58e-06	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—AKT1—coronary artery disease	1.96e-07	1.53e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—NOS3—coronary artery disease	1.93e-07	1.51e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PIK3CA—coronary artery disease	1.81e-07	1.42e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.77e-07	1.38e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.77e-07	1.38e-06	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—AKT1—coronary artery disease	1.66e-07	1.3e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PIK3CA—coronary artery disease	1.65e-07	1.29e-06	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—AKT1—coronary artery disease	1.48e-07	1.16e-06	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—AKT1—coronary artery disease	1.44e-07	1.13e-06	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—AKT1—coronary artery disease	1.35e-07	1.06e-06	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.09e-07	8.52e-07	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—AKT1—coronary artery disease	8.89e-08	6.96e-07	CbGpPWpGaD
